These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 17717859)

  • 1. Aspirin, COX-2, and the risk of colorectal cancer.
    Murashige N; Kami M; Ikeda M
    N Engl J Med; 2007 Aug; 357(8):824-5; author reply 824-5. PubMed ID: 17717859
    [No Abstract]   [Full Text] [Related]  

  • 2. Aspirin, COX-2, and the risk of colorectal cancer.
    Benelli R
    N Engl J Med; 2007 Aug; 357(8):824-5; author reply 824-5. PubMed ID: 17715417
    [No Abstract]   [Full Text] [Related]  

  • 3. Aspirin and the risk of colorectal cancer in relation to the expression of COX-2.
    Chan AT; Ogino S; Fuchs CS
    N Engl J Med; 2007 May; 356(21):2131-42. PubMed ID: 17522398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclooxygenase-2 inhibitors in colorectal cancer prevention: point.
    Arber N
    Cancer Epidemiol Biomarkers Prev; 2008 Aug; 17(8):1852-7. PubMed ID: 18708371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal functional responses to ischaemia-reperfusion injury in normotensive and hypertensive rats following non-selective and selective cyclo-oxygenase inhibition with nitric oxide donation.
    Knight S; Johns EJ
    Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):11-6. PubMed ID: 18047621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Asborin: the carbaborane analogue of aspirin.
    Scholz M; Bensdorf K; Gust R; Hey-Hawkins E
    ChemMedChem; 2009 May; 4(5):746-8. PubMed ID: 19326386
    [No Abstract]   [Full Text] [Related]  

  • 7. Selective COX-2 inhibitors modulate cellular senescence in human dermal fibroblasts in a catalytic activity-independent manner.
    Kim SR; Park JH; Lee ME; Park JS; Park SC; Han JA
    Mech Ageing Dev; 2008 Dec; 129(12):706-13. PubMed ID: 18848576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aspirin as adjuvant therapy for colorectal cancer: a promising new twist for an old drug.
    Neugut AI
    JAMA; 2009 Aug; 302(6):688-9. PubMed ID: 19671913
    [No Abstract]   [Full Text] [Related]  

  • 9. Diabetes, colorectal cancer and cyclooxygenase 2 inhibition.
    Smith CJ; McKay GA; Fisher M
    Int J Clin Pract; 2008 May; 62(5):810-5. PubMed ID: 18373616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antiatherosclerotic mechanism of aspirin: experiment with rabbits].
    Yang XY; Wang L; Zhou N; Zeng HS
    Zhonghua Yi Xue Za Zhi; 2007 Dec; 87(46):3298-301. PubMed ID: 18396630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acetylsalicylic acid regulates MMP-2 activity and inhibits colorectal invasion of murine B16F0 melanoma cells in C57BL/6J mice: effects of prostaglandin F(2)alpha.
    Tsai CS; Luo SF; Ning CC; Lin CL; Jiang MC; Liao CF
    Biomed Pharmacother; 2009 Aug; 63(7):522-7. PubMed ID: 18849138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reverse effect of aspirin: is the prothrombotic effect after aspirin discontinuation mediated by cyclooxygenase 2 inhibition?
    Doutremepuich C; Aguejouf O; Eizayaga FX; Desplat V
    Pathophysiol Haemost Thromb; 2007; 36(1):40-4. PubMed ID: 18332613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclooxygenase-2 inhibitors down-regulate osteopontin and Nr4A2-new therapeutic targets for colorectal cancers.
    Zagani R; Hamzaoui N; Cacheux W; de Reyniès A; Terris B; Chaussade S; Romagnolo B; Perret C; Lamarque D
    Gastroenterology; 2009 Oct; 137(4):1358-66.e1-3. PubMed ID: 19549529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of 2,3-diaryl-1,3-thiazolidine-4-one derivatives as selective cyclooxygenase (COX-2) inhibitors.
    Zarghi A; Najafnia L; Daraee B; Dadrass OG; Hedayati M
    Bioorg Med Chem Lett; 2007 Oct; 17(20):5634-7. PubMed ID: 17822894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and synthesis of new 1,3-benzthiazinan-4-one derivatives as selective cyclooxygenase (COX-2) inhibitors.
    Zarghi A; Zebardast T; Daraie B; Hedayati M
    Bioorg Med Chem; 2009 Aug; 17(15):5369-73. PubMed ID: 19596198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostics for aspirin resistance.
    Gurbel PA; Bilden KP; Tantry US
    Mol Diagn Ther; 2008; 12(1):55-6. PubMed ID: 18288883
    [No Abstract]   [Full Text] [Related]  

  • 17. Mechanistic insights into cyclooxygenase irreversible inactivation by aspirin.
    Tosco P; Lazzarato L
    ChemMedChem; 2009 Jun; 4(6):939-45. PubMed ID: 19301318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of aspirin, nimesulide, and SC-560 on vasopressin-induced contraction of human gastroepiploic artery and saphenous vein.
    Aldasoro M; Mauricio MD; Serna E; Cortina B; Segarra G; Medina P; Vila JM; Flor B; Lluch S
    Crit Care Med; 2008 Jan; 36(1):193-7. PubMed ID: 18090373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aspirin, NSAIDs, and cardiovascular risk: is there a link?
    Kapoor JR
    Am J Med; 2008 Nov; 121(11):e9. PubMed ID: 18954833
    [No Abstract]   [Full Text] [Related]  

  • 20. Reversal of postprandial endothelial dysfunction by cyclooxygenase inhibition in healthy volunteers.
    Signori LU; da Silva AM; Plentz RD; Moreno H; Irigoyen MC; Schaan BD
    J Cardiovasc Pharmacol; 2009 Jul; 54(1):90-3. PubMed ID: 19546816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.